NCT02174991View on ClinicalTrials.gov

A Compassionate Case Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Surgical Intervention

PHASE2UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 28, 2015

Conditions
Glaucoma
Interventions
DRUG

Rho-Kinase Inhibitor (AR-12286)

Trial Locations (1)

10003

Glaucoma Associates of New York, New York

Sponsors
All Listed Sponsors
lead

New York Glaucoma Research Institute

OTHER